JP2024526773A5 - - Google Patents
Info
- Publication number
- JP2024526773A5 JP2024526773A5 JP2024502056A JP2024502056A JP2024526773A5 JP 2024526773 A5 JP2024526773 A5 JP 2024526773A5 JP 2024502056 A JP2024502056 A JP 2024502056A JP 2024502056 A JP2024502056 A JP 2024502056A JP 2024526773 A5 JP2024526773 A5 JP 2024526773A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- cancer
- pharmaceutical composition
- composition according
- sucrose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163222750P | 2021-07-16 | 2021-07-16 | |
| US63/222,750 | 2021-07-16 | ||
| PCT/US2022/073462 WO2023288173A1 (en) | 2021-07-16 | 2022-07-06 | Pharmaceutical compositions of a b7-h3 antibody and use of the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024526773A JP2024526773A (ja) | 2024-07-19 |
| JP2024526773A5 true JP2024526773A5 (https=) | 2025-07-10 |
Family
ID=84920541
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024502056A Pending JP2024526773A (ja) | 2021-07-16 | 2022-07-06 | Ｂ７‐ｈ３抗体の医薬組成物及びその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240336687A1 (https=) |
| EP (1) | EP4370155A4 (https=) |
| JP (1) | JP2024526773A (https=) |
| KR (1) | KR20240038005A (https=) |
| CN (1) | CN117715657A (https=) |
| AU (1) | AU2022310668A1 (https=) |
| CA (1) | CA3224118A1 (https=) |
| IL (1) | IL310187A (https=) |
| MX (1) | MX2024000690A (https=) |
| TW (1) | TW202310874A (https=) |
| WO (1) | WO2023288173A1 (https=) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH12012501751A1 (en) * | 2010-03-04 | 2012-11-12 | Macrogenics Inc | Antibodies reactive with b7-h3, immunologically active fragments thereof and uses thereof |
| WO2019246312A1 (en) * | 2018-06-20 | 2019-12-26 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with an immunomodulator |
| BR112022019073A2 (pt) * | 2020-03-25 | 2022-11-08 | Jiangsu Hengrui Pharmaceuticals Co Ltd | Composição farmacêutica que compreende conjugado anticorpo-fármaco e uso da mesma |
-
2022
- 2022-07-06 EP EP22842996.5A patent/EP4370155A4/en not_active Withdrawn
- 2022-07-06 IL IL310187A patent/IL310187A/en unknown
- 2022-07-06 CN CN202280050225.0A patent/CN117715657A/zh active Pending
- 2022-07-06 US US18/577,945 patent/US20240336687A1/en active Pending
- 2022-07-06 KR KR1020247004914A patent/KR20240038005A/ko active Pending
- 2022-07-06 AU AU2022310668A patent/AU2022310668A1/en active Pending
- 2022-07-06 MX MX2024000690A patent/MX2024000690A/es unknown
- 2022-07-06 JP JP2024502056A patent/JP2024526773A/ja active Pending
- 2022-07-06 WO PCT/US2022/073462 patent/WO2023288173A1/en not_active Ceased
- 2022-07-06 CA CA3224118A patent/CA3224118A1/en active Pending
- 2022-07-12 TW TW111126185A patent/TW202310874A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2981830T3 (es) | Uso de riluzol, profármacos de riluzol o análogos de riluzol con inmunoterapias para tratar cánceres | |
| KR102446673B1 (ko) | 암 치료를 위한 약물의 제조에 있어서 항-pd-1 항체 및 vegfr 억제제의 조합의 용도 | |
| JP2022533578A5 (https=) | ||
| JP2014132009A5 (https=) | ||
| CN115624550B (zh) | 一种用于治疗胃癌的喹啉衍生物 | |
| ES2946472T3 (es) | Agente antitumoral y potenciador del efecto antitumoral | |
| JP2012500180A5 (https=) | ||
| TWI762784B (zh) | Cdk4/6抑制劑與egfr抑制劑聯合在製備治療腫瘤疾病的藥物中的用途 | |
| WO2019057141A1 (zh) | 阿帕替尼和c-Met抑制剂联合在制备治疗肿瘤的药物中的用途 | |
| JP2023542093A (ja) | 抗腫瘍治療におけるチアウラニブと免疫チェックポイント阻害剤との組み合わせの使用 | |
| JP2024513575A (ja) | Ｆｇｆｒ阻害剤及びネクチン－４標的化剤を含む併用療法 | |
| JP7296070B2 (ja) | がん免疫療法アジュバント | |
| JP6063472B2 (ja) | 骨髄増殖性新生物形成および慢性骨髄性白血病を含む、トランスデューシンβ様タンパク質１（ＴＢＬ１）活性に関連する疾患および障害の処置のための方法 | |
| TW200810758A (en) | Potentiator of radiation therapy | |
| ES2685974T3 (es) | Derivados de cefalosporina para tratar el cáncer | |
| CA2914742A1 (en) | Handovers with co-operating cells configured to provide coordinated multi-point transmission/reception | |
| JP2022531980A5 (https=) | ||
| JP2022519923A5 (https=) | ||
| WO2022249141A2 (en) | Cancer therapy using a combination of cdk7 inhibitor with an anti-cancer agent | |
| US20220062294A1 (en) | Pharmaceutical compositions of tetracyclic quinolone analogs and their salts | |
| JP2024526773A5 (https=) | ||
| CN110464845A (zh) | 一种用于乳腺癌免疫治疗的联合用药物组合及其应用 | |
| WO2025085303A1 (en) | Methods and compositions for treating tumors using antibody camptothecin drug conjugates | |
| JP2024525566A5 (https=) | ||
| WO2024028846A1 (en) | Combination therapy for treating cancers |